Investors Wish List
CervoMed (CRVO) Stock Climbs Following Positive Data From A Clinical Trial
Shares of CervoMed Inc. (NASDAQ: CRVO) advanced notably following the release of new clinical results. As of the latest check, CRVO stock was trading at $10.33, marking a 15.03% increase. The company reported positive 32-week data from the Extension phase